Bellevue Life Sciences Ac...
(BLAC)
undefined
undefined%
At close: undefined
11.32
0.00%
After-hours Dec 12, 2024, 02:38 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 |
Revenue | - | - | - | - |
Cost of Revenue | - | - | - | - |
Gross Profit | - | - | - | - |
Operating Income | -1.83M | -35.39K | -3.31K | -23.81K |
Interest Income | - | - | - | - |
Pretax Income | 944.59K | -35.39K | -3.31K | -23.81K |
Net Income | 403.78K | -35.39K | -3.31K | -23.81K |
Selling & General & Admin | 1.83M | 35.39K | 3.31K | 23.81K |
Research & Development | - | - | - | - |
Other Expenses | - | - | - | - |
Operating Expenses | 1.83M | 35.39K | 3.31K | 23.81K |
Interest Expense | - | - | - | - |
Selling & Marketing Expenses | - | - | - | - |
Cost & Expenses | 1.83M | 35.39K | 3.31K | 23.81K |
Income Tax | 540.81K | -228.48K | -236.56K | -206.30K |
Shares Outstanding (Basic) | 5.62M | 9.05M | 7.93M | 7.89M |
Shares Outstanding (Diluted) | 5.62M | 9.05M | 7.93M | 7.89M |
EPS (Basic) | 0.07 | -0.00 | -0.00 | -0.00 |
EPS (Diluted) | 0.07 | -0.00 | -0.00 | -0.00 |
EBITDA | 944.59K | -35.39K | -3.31K | -23.81K |
Depreciation & Amortization | 2.78M | 228.49K | 236.56K | 206.30K |